Faster global financial news!
Samsung Bioepis has signed a 10-year biosimilar supply agreement with Brazil to supply SB12 to its public health system starting in 2027.
South Korean biopharmaceutical company Samsung Bioepis has formed a consortium with Brazilian pharmaceutical company Bionovis and state-owned laboratory Bahiafarma to secure a 10-year biosimilar supply agreement with Brazil's public health system. Under the agreement, Samsung Bioepis will supply the biosimilar SB12 starting in 2027, a move aimed at strengthening its foothold in Latin America's largest pharmaceutical market.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
Previous: South Korean firm Elice's IPO plummeted 32% on its first day, marking the largest decline on Kosdaq this year.
|
Next: Singapore's Senior Minister Shanmugam warned agriculture companies linked to haze, stating the government would take severe measures, leading to a decline in several agricultural stocks.
24H Trending
-
1
JPMorgan Extends JPM Coin to Ethereum for Institutional Clients, bringing permissioned bank money onto another public blockchain.
-
2
Advantage Partners is preparing to launch Japan's first large-scale forestry fund as early as this spring, aiming to consolidate forest resources and generate returns through timber, biomass, and carbon credits.
-
3
Gamium (GMM) Token Analysis and Trading Activity Review
-
4
AI Data Center Bubble Concerns Intensify: NVIDIA-backed Nscale Valuation Halved by Investor Demands, Microsoft Exits Key Project
-
5
Saudi Arabia has postponed its major investor conference, originally scheduled for October 26, to 2027 due to escalating Houthi attacks.
-
6
Nscale, backed by NVIDIA, is reportedly in talks with Anthropic for a $45 billion cloud computing deal.
-
7
JPMorgan Chase: KOSPI fell over 15% last week, with weakening corporate buyback support; tactically cautious but bullish medium-term.
-
8
Trump Administration to remove Chinese AI Deepseek from civilian government agency IT systems, barring purchase of Deepseek related products by government agencies.
-
9
Indian Rupee gains 2% last week, best since March, as bond market falls for nine consecutive weeks and rate hike expectations rise.
-
10
Blockchain Digital Currencies: Core Principles, Market Evolution, and Global Regulatory Overview
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
